One Clear Vision is the leading international charity working for people with Degenerative Vitreous Syndrome (severe eye floaters): raising awareness and promoting a better understanding through fundraising, providing information and support to sufferers and collaborating with eye specialists and researchers to help achieve clear sight for everyone affected.

A view of the sea as seen by somebody with vitreous opacities or eye floaters

Welcome

If you are here because you suffer from Degenerative Vitreous Syndrome, and you are looking for support and guidance, then we hope that in due course this site will offer you all the resources you need to help deal with the condition on a daily basis, and to make a decision on whether treatment is suitable for you.  It may also help you achieve a greater level of support from friends, family and doctors who often do not appreciate the full implications of this potentially disabling vision perception disorder.

Pioneering enzymatic vitreolysis treatment for floaters

A 2007 scientific publication recently came to our attention, "Posterior vitreous detachment and pharmacologic vitreolysis: The New Era of enzymatic vitrectomy". It talked about the use of plasmin, a protease from the patient's own blood, as an adjunct 15 minutes prior to surgical vitrectomy to induce posterior vitreous detachment .

Is there anything positive about PVD floaters?

Vitreous opacities frequently appear with the onset of posterior vitreous detachment (PVD). Although floaters can be distressing and it may be hard to see anything positive in the experience, sufferers may find some peace of mind with the knowledge that PVD induced floaters can suggest a reduced likelihood of developing other, significantly more serious, eye conditions. Indeed, the detachment of the vitreous from the retina has been observed to be beneficial in some cases.

DVS and quality of life

In the latest issue of the American Journal of Ophthalmology, Wagle and associates present interesting new information about the negative impact symptomatic degenerative vitreous floaters have on the quality of life of sufferers.

As Sebag notes in his discussion article in the same edition, investigators found that these patients were willing to take an 11% risk of death and a 7% risk of blindness to get rid of symptoms related to floaters.

Syndicate content

Charity cards

Help raise the profile of eye floaters with One Clear Vision charity cards Christmas box sets now on sale. Visit the online shop.

Research survey

Please take 10 minutes to complete our online survey and add to our research base.

Get involved

One Clear Vision needs you. Find out how you can help.

English

Donate to OCV

Donate to One Clear Vision and help improve the prospects of sufferers of eye floaters

Members of VISION 2020 UK

One Clear Vision is a member of the umbrella group, VISION 2020 UK The Right to Sight

Physician Directory

View our list of ophthalmologists sympathetic to treating vitreous opacities

Poll

What would you be prepared to pay for an effective drug targeted at the symptomatic relief of floaters?
Up to $1000 per year
12%
$2000 per year
8%
$3000 per year
8%
Over $3000 per year
72%
Total votes: 25

Community

Be part of the worldwide eye floater community and add yourself to our world map
Whether you are a sufferer or an interested party, plant your flag on our worldwide map.

Eye on Floaters

Click below for the award winning Helen Keller video on eye floaters

Award winning Helen Keller video